News

May 12, 2025

Drug to slow Alzheimer’s well tolerated outside of clinical trial setting

Side effects of lecanemab are manageable, study finds.

News Release

March 31, 2025

Highly accurate blood test diagnoses Alzheimer’s disease, measures extent of dementia

Could help determine which patients are likely to benefit from new Alzheimer’s drugs.

News Release

March 19, 2025

Anti-amyloid drug shows signs of preventing Alzheimer’s dementia

Clinical trial of people destined to develop early-onset Alzheimer’s disease shows eliminating amyloid from brain may prevent symptoms, supports need for confirmatory studies.

News Release

March 7, 2025

$4.5 million supports pathbreaking neuroimmunology research

Grant funds WashU Medicine’s pursuit of new treatments for Alzheimer’s disease.

News Release

February 10, 2025

Patient defies genetic fate to avoid Alzheimer’s

Study offers clues to treatment, prevention.

News Release

February 4, 2025

International Alzheimer’s prevention trial in young adults begins

WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms arise.

News Release

December 17, 2024

NIH grant funds study of cerebral small vessel disease

Research will look for early warning signs, potential treatment of second-leading cause of dementia.

News Release

November 18, 2024

Researchers define new subtypes of common brain disorder

Artificial intelligence identified 3 subtypes of Chiari type-1 malformations, could improve medical decision making .

News Release

October 30, 2024

Healthy brains suppress inappropriate immune responses

Harnessing this process may offer therapies for neuroinflammatory diseases such as MS, mouse study suggests.

News Release

August 23, 2024

Multiple sclerosis appears to protect against Alzheimer’s disease

Findings could point to new strategies to treat Alzheimer’s.

News Release

July 22, 2024

Can we predict who will develop migraine headaches?

Adolescents focus of research on brain connectivity, hormones, pain sensitivity in determining migraine risk.

News Release

April 4, 2024

CPAP replacement works well for the overweight, not obese, study finds

In the News

March 20, 2024

Thompson named director of pediatric neurosurgery

Physician-scientist’s focus is on pediatric brain tumors.

News Release

March 8, 2024

How the mind works: Thinking about thinking

Investigating how the cells, circuits and structures of the brain give rise to the complex mental functions that make us who we are.

Outlook Magazine

February 23, 2024

Human development: Starting out strong

WashU Medicine researchers are leading efforts to understand the factors that influence brain development.

Outlook Magazine

February 14, 2024

Brain tumors: Fighting with targeted tools

To understand and treat brain tumors we have to attack them from different angles, and tailor therapy to each patient.

Outlook Magazine

January 8, 2024

A ‘unique, indelible impact’: Q&A with Dean Perlmutter

Talent, technologies coalesce to drive revolutionary therapies.

Outlook Magazine

December 13, 2023

Neurosciences on the rise: Launching a new era of progress

Addressing the profound mysteries underlying the functions of the brain and emergence of the mind, we can transform the way people live.

Outlook Magazine

November 15, 2023

Device for noninvasive brain biopsies via blood draw moves closer to market approval

FDA grants WashU-based technology ‘Breakthrough Device’ designation.

News Release

October 2, 2023

$8 million awarded to study root causes of brain cell death in fatal pediatric diseases

Team science approach leverages expertise of researchers from diverse fields.

News Release

March 28, 2023

Rogers, Smyser awarded MERIT grant for research on preterm babies

Grant totaling more than $7 million could be extended in 5 years.

News Release

December 21, 2022

Podcast: Brain-related issues can linger after patients recover from COVID-19

This episode of 'Show Me the Science' discusses one of the most common problems associated with long COVID-19.

Podcast, Show Me the Science

December 14, 2022

WashU, Eisai form drug discovery collaboration

Focus is on therapies for Alzheimer’s, other neurodegenerative diseases.

News Release